NOK 14.0
(-6.35%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 86.38 Million NOK | 23.46% |
2022 | 69.97 Million NOK | 117.16% |
2021 | 32.22 Million NOK | 120.56% |
2020 | 14.6 Million NOK | -16.49% |
2019 | 17.49 Million NOK | -25.29% |
2018 | 23.41 Million NOK | 1868.03% |
2017 | 1.18 Million NOK | -36.03% |
2016 | 1.86 Million NOK | -18.24% |
2015 | 2.27 Million NOK | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q2 | 152.24 Million NOK | 110.73% |
2024 Q1 | 72.24 Million NOK | -16.37% |
2023 Q2 | 53.54 Million NOK | -18.62% |
2023 Q4 | 86.38 Million NOK | 88.59% |
2023 FY | 86.38 Million NOK | 23.46% |
2023 Q1 | 65.79 Million NOK | -5.97% |
2023 Q3 | 45.8 Million NOK | -14.45% |
2022 Q3 | 33.51 Million NOK | -1.76% |
2022 FY | 69.97 Million NOK | 117.16% |
2022 Q2 | 34.11 Million NOK | 0.0% |
2022 Q4 | 69.97 Million NOK | 108.76% |
2021 Q4 | 32.22 Million NOK | 0.0% |
2021 FY | 32.22 Million NOK | 120.56% |
2021 Q2 | 13.58 Million NOK | 0.0% |
2020 Q4 | 14.6 Million NOK | 0.0% |
2020 FY | 14.6 Million NOK | -16.49% |
2019 Q4 | 17.49 Million NOK | 0.0% |
2019 Q2 | 22.57 Million NOK | 0.0% |
2019 FY | 17.49 Million NOK | -25.29% |
2018 Q4 | 23.41 Million NOK | 0.0% |
2018 Q2 | 2.6 Million NOK | 0.0% |
2018 FY | 23.41 Million NOK | 1868.03% |
2017 FY | 1.18 Million NOK | -36.03% |
2017 Q4 | 1.18 Million NOK | 0.0% |
2016 FY | 1.86 Million NOK | -18.24% |
2015 FY | 2.27 Million NOK | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Gentian Diagnostics ASA | 180.58 Million NOK | 52.162% |
Medistim ASA | 505.71 Million NOK | 82.917% |